Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses
Liver hepatocellular carcinoma (LIHC) is a major malignant tumor of the digestive system with a high incidence rate and poor early diagnosis. Coiled-coil domain-containing protein 115 (CCDC115), an accessory component of vacuolar-ATPase with dramatically abnormal expression, is associated with survi...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-09-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023064411 |
| _version_ | 1797669905238065152 |
|---|---|
| author | Chang Su Jing-cheng Yang Zheng Rong Fei Li Lan-xin Luo Guan Liu Cai-yan Cheng Ming-gao Zhao Le Yang |
| author_facet | Chang Su Jing-cheng Yang Zheng Rong Fei Li Lan-xin Luo Guan Liu Cai-yan Cheng Ming-gao Zhao Le Yang |
| author_sort | Chang Su |
| collection | DOAJ |
| description | Liver hepatocellular carcinoma (LIHC) is a major malignant tumor of the digestive system with a high incidence rate and poor early diagnosis. Coiled-coil domain-containing protein 115 (CCDC115), an accessory component of vacuolar-ATPase with dramatically abnormal expression, is associated with survival outcomes of cancer patients. However, the role of CCDC115 in LIHC remains unclear. In this study, we aimed to determine the functional role of CCDC115 in LIHC by examining CCDC115 expression, and its influence on LIHC prognosis. Through extensive statistical analyses, using LIHC patient databases, we observed that CCDC115 expression significantly increased in tumor tissues of LIHC patients. In addition, CCDC115 expression correlated with the poor prognosis. Additionally, CCDC115 was found to be involved in several cancer-related pathways, specifically the PI3K-Akt pathway. The expression of CCDC115 was positively correlated with human leukocyte antigen molecules as well as with immune checkpoint molecules in LIHC patients. We performed in vitro experiments and confirmed that the expression of CCDC115 significantly affects the proliferation potential, metastasis and sorafenib resistance of liver cancer cells, as well as some key protein expression in PI3K-Akt pathway. These results indicate that CCDC115 could serve as a diagnostic and prognostic biomarker of LIHC, and targeting CCDC115 may provide a potential strategy to enhance the efficacy of liver cancer therapy. |
| first_indexed | 2024-03-11T20:51:39Z |
| format | Article |
| id | doaj.art-6d931053f0c84a8580869a5ca235ac8e |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-03-11T20:51:39Z |
| publishDate | 2023-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-6d931053f0c84a8580869a5ca235ac8e2023-10-01T05:58:55ZengElsevierHeliyon2405-84402023-09-0199e19233Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analysesChang Su0Jing-cheng Yang1Zheng Rong2Fei Li3Lan-xin Luo4Guan Liu5Cai-yan Cheng6Ming-gao Zhao7Le Yang8Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, China; Shaanxi Provincial Corps, Chinese People's Armed Police Force, Xi'an, ChinaPrecision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, ChinaPrecision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, ChinaPrecision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, ChinaPrecision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, ChinaDepartment of General Surgery, Tangdu Hospital, Air Force Military Medical University, Xi'an, ChinaPrecision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, China; Institute of Medical Research, Northwestern Polytechnical University, Xi'an, ChinaPrecision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, China; Corresponding author.Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, China; Corresponding author.Liver hepatocellular carcinoma (LIHC) is a major malignant tumor of the digestive system with a high incidence rate and poor early diagnosis. Coiled-coil domain-containing protein 115 (CCDC115), an accessory component of vacuolar-ATPase with dramatically abnormal expression, is associated with survival outcomes of cancer patients. However, the role of CCDC115 in LIHC remains unclear. In this study, we aimed to determine the functional role of CCDC115 in LIHC by examining CCDC115 expression, and its influence on LIHC prognosis. Through extensive statistical analyses, using LIHC patient databases, we observed that CCDC115 expression significantly increased in tumor tissues of LIHC patients. In addition, CCDC115 expression correlated with the poor prognosis. Additionally, CCDC115 was found to be involved in several cancer-related pathways, specifically the PI3K-Akt pathway. The expression of CCDC115 was positively correlated with human leukocyte antigen molecules as well as with immune checkpoint molecules in LIHC patients. We performed in vitro experiments and confirmed that the expression of CCDC115 significantly affects the proliferation potential, metastasis and sorafenib resistance of liver cancer cells, as well as some key protein expression in PI3K-Akt pathway. These results indicate that CCDC115 could serve as a diagnostic and prognostic biomarker of LIHC, and targeting CCDC115 may provide a potential strategy to enhance the efficacy of liver cancer therapy.http://www.sciencedirect.com/science/article/pii/S2405844023064411CCDC115Hepatocellular carcinomaPrognosisPI3K-Akt pathwayDrug resistance |
| spellingShingle | Chang Su Jing-cheng Yang Zheng Rong Fei Li Lan-xin Luo Guan Liu Cai-yan Cheng Ming-gao Zhao Le Yang Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses Heliyon CCDC115 Hepatocellular carcinoma Prognosis PI3K-Akt pathway Drug resistance |
| title | Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses |
| title_full | Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses |
| title_fullStr | Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses |
| title_full_unstemmed | Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses |
| title_short | Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses |
| title_sort | identification of ccdc115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses |
| topic | CCDC115 Hepatocellular carcinoma Prognosis PI3K-Akt pathway Drug resistance |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023064411 |
| work_keys_str_mv | AT changsu identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses AT jingchengyang identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses AT zhengrong identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses AT feili identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses AT lanxinluo identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses AT guanliu identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses AT caiyancheng identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses AT minggaozhao identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses AT leyang identificationofccdc115asanadverseprognosticbiomarkerinlivercancerbasedonbioinformaticsandexperimentalanalyses |